News
All News
Contributors
Money Matters
Media
Expert Interviews
Medical World News
Podcasts
Case Based Roundtable Series
EyeView
Grand Rounds
Insights
Viewpoints
What’s Your WhEYE?
Conferences
Conference Coverage
Conference Listing
Events
Publications
Digital Edition
Europe Ophthalmology Times
Modern Retina
Supplements and Featured Publications
CME
Partners
Subscribe
Resources
Job Board
Sponsored
Spotlight
Retina
Clinical
Geographic Atrophy
Presbyopia
AMD
Biosimilars
COVID-19
Cataract
Cataract Therapeutics
Cornea
DME
Dry Eye
Glaucoma
IOL
OCT
Ocular Allergy
Ocular Surface Disease
Pediatrics
Ptosis
Refractive
Retina
Technology
Therapeutics
Understanding Antibiotic Resistance
Workplace
News
All News
Contributors
Money Matters
Media
Expert Interviews
Medical World News
Podcasts
Case Based Roundtable Series
EyeView
Grand Rounds
Insights
Viewpoints
What’s Your WhEYE?
Conferences
Conference Coverage
Conference Listing
Events
Publications
Digital Edition
Europe Ophthalmology Times
Modern Retina
Supplements and Featured Publications
CME
Partners
Subscribe
Resources
Job Board
Sponsored
Advertisement
AMD
| Biosimilars
| COVID-19
| Cataract
| Cataract Therapeutics
| Clinical Diagnosis
| Cornea
| DME
| Dry Eye
| Gene Therapy
| Geographic Atrophy
| Glaucoma
| IOL
| Imaging
| OCT
| Ocular Allergy
| Ocular Surface Disease
| Optic Relief
| Optometry
| Pediatrics
| Pharmacy
| Practice Management
| Presbyopia
| Ptosis
| Refractive
| Retina
| Surgery
| Technology
| Therapeutics
| Understanding Antibiotic Resistance
| Workplace
View All >>
AMD
Biosimilars
COVID-19
Cataract
Cataract Therapeutics
Clinical Diagnosis
Cornea
DME
Dry Eye
Gene Therapy
Geographic Atrophy
Glaucoma
IOL
Imaging
OCT
Ocular Allergy
Ocular Surface Disease
Optic Relief
Optometry
Pediatrics
Pharmacy
Practice Management
Presbyopia
Ptosis
Refractive
Retina
Surgery
Technology
Therapeutics
Understanding Antibiotic Resistance
Workplace
SPOTLIGHT
-
Retina
Roberto Gonzalez-Salinas, MD
home
/ authors
/ roberto-gonzalez-salinas-md
Articles
Advertisement
Drop shows effectiveness for Demodex blepharitis in phase 2a study
October 6th 2020
Read More
